STAT+: FDA gives a mixed response to a petition seeking greater clinical trial transparency
STAT
FEBRUARY 22, 2024
Food and Drug Administration told an advocacy group that it is not planning to take a tougher stance against wayward clinical trial sponsors and investigators that fail to register studies or report results, a central issue in the ongoing debate over greater transparency into clinical research.
Let's personalize your content